Mary Tyler Moore Vision Initiative Welcomes Regeneron and Adaptive Sensory Technology to Its Consortium
New pharmaceutical and device company members broaden the Consortium's expertise supporting diabetic retinal disease research. ANN ARBOR, Mich., Nov. 5, 2026 /PRNewswire/ -- The Mary Tyler Moore Vision Initiative (MTM Vision) today announced that Regeneron Pharmaceuticals, Inc. has joined...
Covered in this story
Call it yourself
No calls on $NOV yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on NOV →Dalsna Finance is currently tracking 89 stories mentioning NOV, the earliest published 16 Dec 2025.
Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.